碳酸酐酶抑制剂在X连锁视网膜劈裂中的应用:对囊样黄斑病变及视力的影响
回顾性分析36例(68眼)5至61岁X连锁视网膜劈裂患者使用碳酸酐酶抑制剂的情况,45眼(66%)囊样病变减少,20眼(29%)无变化,3眼(4%)加重;治疗期间logMAR视力较治疗前显著改善(P<0.0001),平均ETDRS等效提升0.09(95%CI 0.08-0.11)。
要点
- 碳酸酐酶抑制剂治疗期间,66%的患眼囊样黄斑病变减少,29%无变化,4%加重。
- 治疗期间logMAR视力较治疗前显著改善(P<0.0001),平均ETDRS等效提升0.09(95%CI 0.08-0.11)。
- 全体36例患者平均视力改善幅度不大,但个体患者改善更显著。
核心结论
- 在36例X连锁视网膜劈裂患者中,碳酸酐酶抑制剂治疗期间平均视力改善虽具统计学显著性但幅度不大,个体患者改善更显著,高比例病例囊样黄斑病变 extent 改善。
研究设计与样本
- 回顾性分析,纳入36例(68眼)5至61岁X连锁视网膜劈裂患者,监测其使用碳酸酐酶抑制剂期间的情况。
主要发现
- 45眼(66%)在使用碳酸酐酶抑制剂期间囊样病变减少,20眼(29%)无囊样变化,3眼(4%)较治疗前加重。
- 治疗期间logMAR视力较治疗前显著改善(P<0.0001),估计平均ETDRS等效提升0.09(略低于ETDRS视力表一行),95%CI为0.08至0.11。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate changes in cystic-appearing macular lesions and visual acuity in patients with X-linked retinoschisis while being treated with a carbonic anhydrase inhibitor. METHODS: A retrospective analysis of 68 eyes from 36 patients between the ages of 5 years and 61 years with X-linked retinoschisis were monitored while on a carbonic anhydrase inhibitor. Macular cystic-appearing lesions were monitored with optical coherence tomography. Snellen visual acuity measurements were converted to logarithm of the minimum angle of resolution equivalent Early Treatment Diabetic Retinopathy Study letters for analysis. Analyses for changes in both visual acuity and macular cysts included comparisons between treatment and pretreatment segments. RESULTS: Forty-five eyes (66%) had a reduction of their cysts while on a carbonic anhydrase inhibitor. Twenty eyes (29%) showed no cystic change, whereas 3 eyes (4%) demonstrated worsening of their cysts with treatment when compared with pretreatment. There was a statistically significant improvement in logarithm of the minimum angle of resolution visual acuity while on treatment relative to pretreatment (P < 0.0001). The estimated average Early Treatment Diabetic Retinopathy Study equivalent improvement was 0.09 (slightly less than one line on the Early Treatment Diabetic Retinopathy Study chart) with a 95% confidence interval of 0.08 to 0.11. CONCLUSION: Considering the entire 36 patients in this cohort, while statistically significant, the average improvement in visual acuity was modest. Nonetheless, in individual patients, the improvement was more substantial. Improvement in the extent of cystic macular lesions was observed in a high percentage of cases.
引用
- Andreuzzi P, Fishman GA, Anderson RJ, et al. USE OF A CARBONIC ANHYDRASE INHIBITOR IN X-LINKED RETINOSCHISIS: Effect on Cystic-Appearing Macular Lesions and Visual Acuity. Retina. 2017. PMID: 27828908. doi:10.1097/IAE.0000000000001379
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。